Advertisement

Topics

Glaukos Corporation to Release Third Quarter 2017 Financial Results after Market Close on November 7

07:00 EDT 24 Oct 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Conference Call and Webcast Scheduled for 1:30 p.m. PST Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures desi...

Other Sources for this Article

Glaukos Corporation
Sheree Aronson
VP, Investor Relations
949-481-0361
saronson@glaukos.com

NEXT ARTICLE

More From BioPortfolio on "Glaukos Corporation to Release Third Quarter 2017 Financial Results after Market Close on November 7"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...